About
News
Products
Research
Events
Contact
HYDROPHILIC ACRYLIC INJECTABLE IOL WITH
AMON-APPLE ENHANCED SQUARE EDGE
  

In 1981 Rayner IOLs were the first IOLs to be approved as safe and effective by the US Food and Drug Administration (FDA). The C-flex injectable IOL is approved since May 2007 by the FDA. Registration of the range of lens products is in process with the North American authorities. As such some of these products may not yet be available in the USA and Canada.

Rayner logo

     

The Rayner C-flex (570C) IOL
•FDA Approved.
•Patented AVH Technology® for perfect centration and stability
•Unique Amon-Apple Enhanced Square Edge for reduced PCO
•Manufactured from Rayacryl® hydrophilic acrylic co-polymer for:
- High biocompatibility
- Low PCO
- Optical purity – no vacuoles or glistenings
- Low Silicone Oil adherence
- Superb handling characteristics.

Power Availability
•+8.0D to +30.0D in 0.5D increments
•+30.0D to +34.0D in 1.0D increments
•+18.0D to +23.75D in 0.25D increments.

Optic Diameter of 5.75 mm and Overall Length of 12.00mm
Estimated SRK A-Constant 118.0
Theoretical ACD 4.97

The Rayner Single Use Soft-Tipped Injector
•Syringe-shaped plastic injector with round nozzle
•Sub 3.0 mm incision size
•Convenience
•Safety

Presentation
The Rayner C-flex (570C) hydrophilic acrylic injectable IOL
is supplied in 0.9% saline solution in a pouched blister pack,
sterilised by moist heat and presented in a convenient, ready
to use Lens Injection System Pack containing:
•One C-flex injectable IOL
•One Rayner Single Use Soft-Tipped Injector


View the “We have the Edge” Product Video >>

View “The Transscleral fixation of foldable IOLs” Video >>


Read about AVH Technology® >>
Read about Enhanced Square Edge Technology >>
Read about Rayacryl® >>
Read about the Single Use Soft-Tipped Injector >>